Meet the top billionaires of the healthcare industry

Amy Baxter | | Health Exec | Management

The healthcare industry is projected to make up 20% of U.S. GDP in the coming years, and the growing sector has created some very wealthy companies and owners.

Bloomberg ranked the 500 richest people in the world in its Bloomberg Billionaires Index, with several healthcare names making the list.

Here are the five richest people in healthcare and their overall rank in the full list:

89. Carl Cook––$16B

Owner and CEO of medical device manufacturer Cook Group, Carl Cook was ranked No. 89 in the overall list and was the richest healthcare person. His Bloomington, Indiana-based company produces products such as catheters, dilators, stents and wire guides, according to Bloomberg. Cook Group reported about $2.4 billion in 2018 revenues.

100. Zhong Huijan––$14.4B

Zhing is the founder and chairman of Hansoh Pharmaceutical Group, which is the largest maker of psychotropic drugs in China. The company’s chemotherapy drug currently has about 40% of the China market, according to Bloomberg. Hansoh produces roughly 50 medicines and had $1.1 billion in revenue in 2018.

102. Thomas Frist––$14.4B

With ownership of 20% of HCA Healthcare, Frist is one of the wealthiest people in healthcare. The company, which is based in Nashville and is an administrator of 300 hospitals and surgery centers in its network, had one of biggest ever private equity buyout deals ever in 2006. The company reported $46.7 billion in revenue in 2018.

107. Sun Piaoyang––$13.5B

Sun is the former leader and chairman of a Chinese producer of anti-cancer drugs, Jiangsu Hengrui Medicine. The company, which reported revenue of $2.6 billion in 2018, makes anti-tumor, anti-infective and painkiller drugs.

150. Cen Jud––$10.6B

Cen is also a part of Jiangsu Hengrui Medicine as a shareholder. The company has produced three billionaires.

See the full list here.

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

FDA issues Class I recall on counterfeit infusion pump batteries
FDA issues alert on PCNL sheath safety after patient death
Bipartisan bills in Congress would force insurance companies, PBMs to sell pharmacies
Anthem BCBS reverses course on anesthesia time limits
FDA issues Class I recall on insulin syringes due to risk of death
FDA issues Class I recall on insertion tubes after manufacturing error

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.